Cytisinicline, a plant-based alkaloid used as a smoking cessation ingredient available OTC in some Central and Eastern Europe countries, has shown strong results in two phase 3 studies by a US firm preparing to ask the Food and Drug Administration for approval as a new drug.
Although Achieve Life Sciences Inc. would seek approval of cytisinicline as an Rx smoking cessation drug, the ingredient – commonly...







